Live Las Vegas CME | February 27-March 1, 2019

Westgate Las Vegas Resort & Casino | 15 Contact Hours

las-vegas-cme-live-cme-clinical-medical-cme-live-pharmacy-ce

Conference as low as $575

Hotel as low as $85

Registration Deadline
Discounted Advanced Registration expires January 27, 2019

Westgate Las Vegas Resort & Casino
3000 Paradise Road
Las Vegas, NV 89109

Live Pharmacy CE & Medical CME in Las Vegas

Join us in Las Vegas for live pharmacy CE & medical CME,  vibrant nightlife, shows and fine dining. This conference, Providing Better Patient Care 2019, is hosted at the Westgate Las Vegas Resort & Casino, February 27 - March 1. This conference provides 15 contact hours (1.5 CEU) over three days, 5 hours per day, of live AAFP/ AMA PRA Category 1™, ACPE and pharmacology CE/ CME credit.

Treat yourself this February and live it up on the Las Vegas strip for 15 credit hours. With small class sizes and clinical faculty from medical & pharmacy schools, our live Las Vegas CME is perfect for physicians, pharmacists, physician assistants, nurses & nurse practitioners. We travel to Las Vegas for live pharmacy CE and medical CME four times each year!

This live CE / CME experience is accredited for MDs, PAs, Pharms, Pharm Techs, NPs and Nurses!

Want more information?

Hotel Information

Westgate Las Vegas Resort and Casino
3000 Paradise Rd.
Las Vegas, NV 89109
Map

Hotel Reservations: Click here to reserve your room online or call 1-800-635-7711 and mention our group code, SGULS9F.

A block of rooms have been reserved for February 26 – March 1, 2019. The discounted room rate will be available until January 27, 2019. Certain room types may be sold out as the conference date approaches.

  • Premium Room – $85.00
  • Hotel Resort Charge – $24.00

Check In Time: 3:00 PM
Check Out Time: 11:00 AM

The above guest room rates do not include state and local taxes, currently at 13.3%, and are subject to change. Room deposit is refundable if reservation is canceled at least 3 days prior to scheduled arrival.

Hotel Amenities & Local Attractions

  • Variety of suites and onsite amenities.
  • Onsite Las Vegas Monorail to easily access other Las Vegas attractions.
  • World’s Largest Race & Sports Book.
  • Extensive dining options, including The Edge Steakhouse and the world-famous Benihana.
  • Newly opened Serenity Spa.
  • Registered guests can take a dip in the outdoor pool or tee off next door at Las Vegas Country Club.

Westgate Las Vegas Resort & Casino

 

Conference Registration

Discounted Advanced Registration*:

3 Day Fee: $575

2 Day Fee: $475

1 Day Fee: $375
*Expires January 27, 2019

Regular Registration:

3 Day Fee: $625

2 Day Fee: $525

1 Day Fee: $425

*Conference Surcharge (if not staying at hotel) – $50

Registration Details

Conference registration includes workshop attendance, handouts, breakfast or refreshments during the meetings and documentation of continuing education credit*.

Spouses, family and friends are welcome and do not need to register unless they attend the educational sessions. Special seminar fees are available for non-professional accompanying persons who wish to attend one or more session (no special receipt, certification or credit issued).

Conference Credit

University Learning Systems ACPE Pharmacy CE

University Learning Systems is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. These programs are accredited for pharmacists and pharmacist technicians.

  • Session 1: 5 Contact Hours ACPE UAN 0741-0000-19-004-L01-P, 0741-0000-19-004-L01-T, Activity: Application
  • Session 2: 5 Contact Hours ACPE UAN 0741-0000-19-005-L01-P, 0741-0000-19-005-L01-T, Activity: Application
  • Session 3: 5 Contact Hours ACPE UAN 0741-0000-19-006-L01-P, 0741-0000-19-006-L01-T, Activity: Knowledge

Physicians: Application for CME credit from the American Academy of Family Physicians (AAFP) is planned.  AAFP Prescribed credit is accepted by the American Medical Association as equivalent to AMA PRA Category 1 Credit™ toward the AMA Physician’s Recognition Award.  When applying for the AMA PRA, Prescribed credit earned must be reported as Prescribed, not as Category 1.

Accreditation

Conference Policies

Update in the Management of Headaches and Seizure Disorders, Polypharmacy and the Elderly

5 hours | Wednesday, 2/27/2019
Check-in and Breakfast: 7:30AM
Educational Session: 8:00AM – 1:30PM

At the conclusion of this program, the participant will be able to:

What a Headache! Clinical Review of Different Headaches with corresponding Treatments

  • Review briefly risk factors, pathophysiology, and clinical presentation of cluster, tension, and migraine headaches.
  • Describe various treatment and preventative strategies of each type of headache when applicable.
  • Illustrate appropriate treatments through patient cases

Seize the day! Update in the Management of Epilepsy

  • Summarize different seizure types requiring therapy.
  • Review briefly current available options for epilepsy treatment.
  • Describe newer treatments in the management of epilepsy

Polypharmacy and the Elderly: Minimizing Untoward Effects through Prudent Prescribing

  • Summarize factors leading to polypharmacy in the elderly.
  • Define inappropriate medications for elderly patients.
  • Describe tools to screen patients for polypharmacy.
  • Describe best practices for limiting adverse drug events in “necessary” medications.
  • Use case studies to illustrate possible polypharmacy interventions.

Pharmacy Technicians:  TBD

 

Expert Speaker

Christopher M. Bland, Pharm.D., FCCP, FIDSA, BCPS

Clinical Associate Professor,  University of Georgia College of Pharmacy; Clinical and Administrative Pharmacy, Clinical Pharmacy Specialist, St. Joseph’s/Candler Health System,  Savannah, Georgia.

 

New Cholesterol Treatment Guidelines: Has the Treatment Paradigm Changed?

5 hours | Thursday, 2/28/2019
Check-in and Breakfast: 7:30AM
Educational Session: 8:00AM – 1:30PM

  • Explain lifestyle modifications that are recommended in patients with hypercholesterolemia
  • Compare and contrast lipid-lowering medications used in the treatment of hypercholesterolemia and hypertriglyceridemia
  • Evaluate and explain the treatment approach recommended in the 2018 ACC-AHA cholesterol guideline to treat patients with dyslipidemia
  • Summarize the long-term evidence of with statin and nonstatin therapies in the management of patients with hypercholesterolemia
  • Discuss the clinical effects of newer and emerging lipid-lowering medications
  • Interpret results from large outcome studies evaluating lipid-lowering drug therapies
  • Compare and contrast other cardiovascular drug treatments that are used to reduce risk of CV events in primary and secondary prevention patients
  • Identify which types of patients with hypertriglyceridemia should be treated with specific triglyceride lowering medications
  • Create treatment plans for patients presenting with various lipid disorders

Expert Speaker

Joseph-Saseen-PharmD-FCCP-FNLA-BCPS-CLS

Joseph Saseen, Pharm.D., FASHP, FCCP, BCPS, BCACP

Professor and Vice Chair, Department of Clinical Pharmacy; Professor, Department of Family Medicine, University of Colorado Anschutz Medical Campus, Aurora, CO.  Dr. Saseen has NO financial arrangements with any corporate organization that might have an interest in the subject being presented.

 

Opioids, Cannabinoids and Gabapentenoids:  Defining the Best Pharmacological Practice Model for the Treatment of Pain

5 hours | Friday, 3/2019
Check-in and Breakfast: 7:30AM
Educational Session: 8:00AM – 1:30PM

 At the conclusion of this program, the participant will be able to:

  • Discuss the burden of opioid misuse and abuse on the individual and society.
  • Differentiate addiction, physical dependency, tolerance and hyperalgesia.
  • Describe the similarities and differences in the mechanism of action for opioids, cannabinoids and gabapentenoids.
  • Compare and contrast the current best practice model for the use of opioids, cannabinoids and gabapentenoids in: a) acute postoperative pain; b) chronic low back pain; c) neuropathic pain;  d) fibromyalgia;  e) end-of-life pain crisis.
  • Describe how to calculate morphine-equivalent dosages (MED).
  • Demonstrate the value of  morphine-equivalent dosages (MED) in determining the benefit and safety of opioids in the treatment of pain.
  • Identify typical characteristics of patients who would be identified as “high risk” , “moderate risk” and “low risk” for misusing, abusing or diverting opioids.
  • Describe the best practice model for properly monitoring patients on opioids.
  • Describe how a provider should counsel patients who are started on opioids to minimize the risks of adverse reactions, over-dosage and inappropriate compliance.
  • Identify examples of opioids products that have “abuse-deterrent” technology and be able to recommend to prescribers how these products could be utilized to improve patient and community safety.
  • Compare and contrast the most common cannabinoids found in marijuana with regards to their benefits and risks in managing pain.
  • Compare and contrast the following gabapentenoids with respect to their benefits and risks in managing pain:  a) gabapentin (Neurontin); b) Horizant;  c) Gralise; and, d) Lyrica.
  • Describe the risks of combining opioids with:  a) benzodiazepines; b) alcohol; c) gabapentenoids; and, d) cannabinoids.
  • Describe the role of naloxone in preventing deaths from overdosages.

Pharmacy Technicians:

  • Discuss the burden of opioid misuse and abuse on the individual and society.
  • Differentiate addiction, physical dependency, tolerance and hyperalgesia.
  • Identify typical characteristics of patients who would be identified as “high risk” , “moderate risk” and “low risk” for misusing, abusing or diverting opioids.
  • Identify examples of opioids products that have “abuse-deterrent” technology and be able to recommend to prescribers how these products could be utilized to improve patient and community safety.
  •  Compare and contrast the most common cannabinoids found in marijuana.
  • Describe the risks of combining opioids with:  a) benzodiazepines; b) alcohol; c) gabapentenoids; and, d) cannabinoids.
  • Describe the role of naloxone in preventing deaths from overdosages.

Expert Speaker

Gregory-Holmquist-PharmD-CPE

Gregory L. Holmquist, Pharm D.

Pain and Palliative Care Pharmacist, Specialist, Palliative Care Strategies, Everett, Washington.

Dr. Holmquist has NO financial arrangements with any corporate organization that might have an interest in the subject being presented.

 

Conference Location

Westgate Las Vegas Resort & Casino

3000 Paradise Road

Las Vegas, NV 89109

702-732-5111

Map

Group Reservations

Local Transportation

About Las Vegas

From the bright lights of the Strip to the rugged desert, Las Vegas has something for everyone. Where else can you visit a National Park, ride a roller coaster, take in a show and enjoy world class dining all in one day? That’s Las Vegas!

Local Weather

Local Activities and Attractions

clinical-pharmacology-ce-las-vegas